Trial Profile
Symptomatic versus Endoscopic approach for the Diagnosis and Initial treatment of Gastroesophageal Reflux Disease using GerdQ
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2012
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- Acronyms GMP
- Sponsors AstraZeneca
- 30 May 2011 New source identified and integrated.
- 27 May 2011 New trial record
- 01 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.